血小板の世界市場

血小板の世界市場は2030年までに67億米ドルに達する見込み

2024年に57億米ドルと推定される血小板の世界市場は、分析期間2024-2030年にCAGR 2.9%で成長し、2030年には67億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるアフェレシス由来血小板は、CAGR 3.5%を記録し、分析期間終了までに41億米ドルに達すると予想されます。全血由来血小板セグメントの成長率は、分析期間中CAGR 2.0%と推定されます。

米国市場は15億米ドルと推定、中国はCAGR 5.7%で成長すると予測

米国の血小板市場は2024年に15億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに13億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは5.7%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.1%と2.3%と予測されています。欧州では、ドイツがCAGR 1.6%で成長すると予測されています。

世界の血小板市場- 主要動向と促進要因まとめ

現代のヘルスケアで血小板の需要が増加している理由とは？

血小板は、血液凝固、創傷治癒、免疫反応において重要な役割を担っており、外傷治療、手術、がん治療、血液疾患など様々な治療において不可欠なものとなっています。血小板輸血は、化学療法や臓器移植を受ける患者、あるいは血小板減少症（血小板数が少ない）の患者にとって救命処置です。がん、自己免疫疾患、慢性血液疾患の有病率の増加が、世界中の病院、血液銀行、輸血センターにおける血小板の需要を大きく牽引しています。

血小板輸血の必要性は、化学療法や放射線治療がしばしば骨髄機能を抑制し、血小板産生の減少につながる腫瘍学において特に高いです。さらに、外科手術や複雑な医療介入の増加も、血小板輸血への依存度を高める一因となっています。血小板輸血は非常に重要であるにもかかわらず、保存期間が短く（5～7日間）、細菌汚染の危険性があるため、血小板には特有の課題があります。このような課題に対処するため、ヘルスケアシステムは血小板保存技術の改善、病原体低減技術、そして安定した安全な血小板供給を確保するための高度なドナー募集戦略に投資しています。

技術の進歩は血小板の収集、保存、利用をどのように向上させていますか？

血小板の収集、保存、輸血法における重要な技術革新は、血小板療法の効率と安全性を向上させています。最も注目すべき進歩の一つはアフェレーシス技術の使用であり、これはドナーから血小板を直接採取し、残りの血液成分を戻すことを可能にします。アフェレーシス由来の血小板は、全血由来の血小板よりも収率が高く、免疫反応のリスクが減少し、保存可能期間が長いため好まれています。さらに、アフェレーシス装置の自動化によって収集効率が向上し、血液バンクはより少ない提供量で需要の増加に対応できるようになりました。

血小板技術におけるもう一つの画期的な進歩は、紫外線（UV）と化学治療を使って血小板ユニット内のウイルス、細菌、その他の汚染物質を不活性化する病原体減少システムの開発です。INTERCEPTやMirasolを含むこれらの技術は、血小板機能を維持しながら感染症のリスクを低減することにより、輸血の安全性を高めています。さらに、凍結保存された血小板や合成血小板代替物の調査も勢いを増しており、血小板の保存期間を延長し、救急医療や軍事医療における利用しやすさを向上させる可能性があります。AIを活用した在庫管理システムが血小板サプライチェーンを最適化することで、ヘルスケアプロバイダーは血小板の入手可能性をより適切に管理し、無駄を減らすことができるため、タイムリーで効率的な輸血が可能になります。

血小板業界の成長を牽引する市場動向は？

血液および腫瘍性疾患の罹患率の上昇は、血小板市場の成長を牽引する最も重要な動向の一つです。がん診断の増加と血小板輸血を必要とする積極的な治療プロトコールにより、需要は一貫して増加すると予想されます。さらに、外傷治療センターや高度な外科手術の拡大により、特に救急医療や救命医療の現場では信頼性の高い血小板供給へのニーズが高まっています。

市場に影響を与えるもう一つの主要動向は、個別化医療と精密医療へのシフトです。遺伝子検査や分子診断の進歩により、希少血液疾患患者や移植患者など特定の患者集団に合わせた血小板療法が可能となっています。さらに、血小板提供に関する意識の高まりは、適切な血小板供給を維持するために自発的なアフェレシス提供を奨励し、ターゲットを絞ったドナー募集プログラムにつながっています。血液バンキングにおけるAIとブロックチェーン技術の統合は、ドナーの追跡、輸血モニタリング、在庫管理をさらに合理化し、血小板不足を減らし、輸血結果を改善しています。

血小板市場の将来を形作る主な成長促進要因は何か？

血小板市場の成長は、血小板輸血を必要とする疾患の有病率の増加、血小板の保存と処理の進歩、世界のヘルスケアインフラの拡大など、いくつかの重要な要因によってもたらされます。主な成長要因の1つは、白血病、リンパ腫、骨髄障害の治療が血小板サポートに大きく依存する腫瘍学および血液学における血小板輸血の需要増加です。加えて、高齢化も血小板利用の増加に寄与しています。高齢患者は心血管疾患や外科的介入など、輸血を必要とする状態に陥りやすいからです。

市場を形成するもう一つの重要な促進要因は、バイオ製造と血小板代替物の進歩です。実験室で培養された血小板や人工血小板模倣ナノ粒子の調査は、血小板の利用可能性を拡大し、サプライチェーンの制約を克服する新たな可能性を開いています。さらに、献血を促進する政府の取り組みとドナースクリーニング技術の進歩は、より安全で効率的な血小板採取を保証しています。ヘルスケア・システムが輸血の安全性、効率性、アクセシビリティを優先するにつれて、血小板の需要は増加し、世界中で収集、保存、治療用途のさらなる技術革新が推進されると予想されます。

セグメント

血小板タイプ（アフェレーシス由来血小板、全血由来血小板）、用途（血小板減少症用途、血液腫瘍用途、周術期適応症用途、血友病用途、血小板機能障害、その他用途）、最終用途（病院最終用途、外来手術センター最終用途、その他最終用途）

調査対象企業の例

• Aggredyne Inc.
• American National Red Cross
• Australian Red Cross
• Blood Centers of America
• Brazilian Red Cross
• Canadian Blood Services
• European Blood Alliance
• F. Hoffmann-La Roche Ltd
• French Red Cross
• German Red Cross
• Haemonetics Corporation
• Indian Red Cross Society
• Italian Red Cross
• Japanese Red Cross Society
• OneBlood
• PerkinElmer Inc.
• South African National Blood Service
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• Werfen, S.A.

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Blood Platelets Market to Reach US$6.7 Billion by 2030

The global market for Blood Platelets estimated at US$5.7 Billion in the year 2024, is expected to reach US$6.7 Billion by 2030, growing at a CAGR of 2.9% over the analysis period 2024-2030. Apheresis Derived Platelets, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in the Whole-Blood Derived Platelets segment is estimated at 2.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 5.7% CAGR

The Blood Platelets market in the U.S. is estimated at US$1.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 5.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Global Blood Platelets Market - Key Trends & Drivers Summarized

Why Is the Demand for Blood Platelets Increasing in Modern Healthcare?

Blood platelets play a crucial role in clotting, wound healing, and immune responses, making them essential in various medical treatments, including trauma care, surgeries, cancer therapies, and hematologic disorders. Platelet transfusions are a lifesaving intervention for patients undergoing chemotherapy, organ transplants, or those with conditions such as thrombocytopenia (low platelet count). The increasing prevalence of cancer, autoimmune diseases, and chronic blood disorders has significantly driven the demand for blood platelets in hospitals, blood banks, and transfusion centers worldwide.

The need for platelet transfusions is particularly high in oncology, where chemotherapy and radiation treatments often suppress bone marrow function, leading to decreased platelet production. Additionally, the rise in surgical procedures and complex medical interventions has contributed to the growing reliance on platelet transfusions. Despite their critical importance, blood platelets present unique challenges due to their short shelf life (5-7 days) and the risk of bacterial contamination. To address these challenges, healthcare systems are investing in improved platelet storage techniques, pathogen reduction technologies, and advanced donor recruitment strategies to ensure a stable and safe platelet supply.

How Are Technological Advancements Enhancing Blood Platelet Collection, Storage, and Utilization?

Significant innovations in platelet collection, storage, and transfusion practices are improving the efficiency and safety of platelet therapy. One of the most notable advancements is the use of apheresis technology, which allows for the direct collection of platelets from a donor while returning the remaining blood components. Apheresis-derived platelets are preferred over whole blood-derived platelets due to their higher yield, reduced risk of immune reactions, and longer shelf life. Additionally, automation in apheresis machines has improved collection efficiency, enabling blood banks to meet increasing demand with fewer donations.

Another breakthrough in platelet technology is the development of pathogen reduction systems, which use ultraviolet (UV) light and chemical treatments to inactivate viruses, bacteria, and other contaminants in platelet units. These technologies, including INTERCEPT and Mirasol, are enhancing transfusion safety by reducing the risk of infections while preserving platelet function. Additionally, research into cryopreserved platelets and synthetic platelet substitutes is gaining momentum, with the potential to extend platelet shelf life and improve accessibility in emergency and military medicine. As AI-driven inventory management systems optimize platelet supply chains, healthcare providers can better manage platelet availability and reduce wastage, ensuring timely and efficient transfusions.

Which Market Trends Are Driving Growth in the Blood Platelets Industry?

The rising incidence of hematologic and oncologic diseases is one of the most significant trends driving growth in the blood platelets market. With increasing cancer diagnoses and aggressive treatment protocols requiring platelet transfusions, demand is expected to grow consistently. Additionally, the expansion of trauma care centers and advanced surgical procedures has heightened the need for reliable platelet supplies, particularly in emergency and critical care settings.

Another key trend influencing the market is the shift toward personalized and precision medicine. Advances in genetic testing and molecular diagnostics are enabling tailored platelet therapies for specific patient populations, such as those with rare blood disorders or transplant recipients. Additionally, increasing awareness about platelet donation has led to targeted donor recruitment programs, encouraging voluntary apheresis donations to maintain an adequate platelet supply. The integration of AI and blockchain technology in blood banking is further streamlining donor tracking, transfusion monitoring, and inventory management, reducing platelet shortages and improving transfusion outcomes.

What Are the Key Growth Drivers Shaping the Future of the Blood Platelets Market?

The growth in the blood platelets market is driven by several key factors, including the increasing prevalence of diseases requiring platelet transfusions, advancements in platelet storage and processing, and the expansion of global healthcare infrastructure. One of the primary growth drivers is the rising demand for platelet transfusions in oncology and hematology, where treatments for leukemia, lymphoma, and bone marrow disorders heavily rely on platelet support. Additionally, the aging population is contributing to increased platelet utilization, as elderly patients are more prone to conditions that require transfusions, such as cardiovascular diseases and surgical interventions.

Another crucial driver shaping the market is the advancement of biomanufacturing and platelet substitutes. Research into lab-grown platelets and artificial platelet-mimicking nanoparticles is opening new possibilities for extending platelet availability and overcoming supply chain limitations. Furthermore, government initiatives promoting blood donation and advancements in donor screening technologies are ensuring safer and more efficient platelet collection practices. As healthcare systems prioritize transfusion safety, efficiency, and accessibility, the demand for blood platelets is expected to rise, driving further innovation in collection, storage, and therapeutic applications worldwide.

SCOPE OF STUDY:

The report analyzes the Blood Platelets market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Platelet Type (Apheresis Derived Platelets, Whole-Blood Derived Platelets); Application (Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders, Other Applications); End-Use (Hospitals End-Use, Ambulatory Surgical Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

• Aggredyne Inc.
• American National Red Cross
• Australian Red Cross
• Blood Centers of America
• Brazilian Red Cross
• Canadian Blood Services
• European Blood Alliance
• F. Hoffmann-La Roche Ltd
• French Red Cross
• German Red Cross
• Haemonetics Corporation
• Indian Red Cross Society
• Italian Red Cross
• Japanese Red Cross Society
• OneBlood
• PerkinElmer Inc.
• South African National Blood Service
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• Werfen, S.A.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Blood Platelets - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Thrombocytopenia and Cancer-Related Conditions Throws the Spotlight on Platelet Transfusion Demand
  • Surge in Chemotherapy and Bone Marrow Treatments Propels Growth in Platelet Supply Requirements
  • Aging Global Population Expands the Addressable Market for Platelet-Based Therapies and Supportive Care
  • Advancements in Apheresis Technologies Strengthen the Business Case for High-Yield Platelet Collection Systems
  • Increasing Emphasis on Blood Component Separation Drives Adoption of Platelet-Rich Plasma (PRP) Applications
  • Rising Popularity of Platelet-Rich Plasma in Regenerative Medicine Generates New Market Frontiers Beyond Transfusion
  • Growing Demand for Leucoreduced and Pathogen-Free Platelets Spurs Technological Innovation in Processing Equipment
  • Expansion of Blood Donation Infrastructure and Apheresis Donor Pools Drives Availability and Market Penetration
  • Technological Enhancements in Cold Storage and Extended Shelf Life Propel Logistics Optimization and Broader Reach
  • Rising Awareness and Government Campaigns Around Voluntary Blood Donation Generate Consistent Supply Opportunities
  • Emergence of Platelet Substitutes and Synthetic Alternatives Sparks Innovation-Led Disruption and New Research Avenues
  • Growing Demand from Critical Care, Trauma, and Surgical Units Accelerates Market Uptake in Emergency Settings
  • Integration of Data-Driven Blood Bank Management Systems Drives Operational Efficiency and Demand Forecasting Accuracy
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Blood Platelets Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Blood Platelets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Blood Platelets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Blood Platelets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Apheresis Derived Platelets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Apheresis Derived Platelets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Apheresis Derived Platelets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Whole-Blood Derived Platelets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Whole-Blood Derived Platelets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Whole-Blood Derived Platelets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Ambulatory Surgical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Ambulatory Surgical Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Thrombocytopenia Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Thrombocytopenia Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Thrombocytopenia Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Hemato-Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Hemato-Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Hemato-Oncology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Perioperative Indications Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Perioperative Indications Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Perioperative Indications Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Hemophilia Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Hemophilia Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Hemophilia Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Platelet Function Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Platelet Function Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Platelet Function Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Blood Platelets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Blood Platelets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • Blood Platelets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 65: China Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Blood Platelets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Blood Platelets by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Blood Platelets by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Blood Platelets by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Blood Platelets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 86: France Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Blood Platelets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Blood Platelets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 113: UK Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Blood Platelets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Blood Platelets by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Blood Platelets by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Blood Platelets by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Blood Platelets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • Blood Platelets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 170: India Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Blood Platelets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Blood Platelets by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Blood Platelets by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Blood Platelets by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Blood Platelets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Blood Platelets by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Blood Platelets by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Blood Platelets by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Blood Platelets Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Blood Platelets by Platelet Type - Apheresis Derived Platelets and Whole-Blood Derived Platelets Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Blood Platelets by Platelet Type - Percentage Breakdown of Value Sales for Apheresis Derived Platelets and Whole-Blood Derived Platelets for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Blood Platelets by End-Use - Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Blood Platelets by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgical Centers End-Use, Other End-Uses and Hospitals End-Use for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Blood Platelets by Application - Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Blood Platelets by Application - Percentage Breakdown of Value Sales for Thrombocytopenia Application, Hemato-Oncology Application, Perioperative Indications Application, Hemophilia Application, Platelet Function Disorders and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION